These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 17188882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
    Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M.
    Neurosci Lett; 2006 Jun 19; 401(1-2):183-7. PubMed ID: 16581184
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease.
    Dong Z, Wolfer DP, Lipp HP, Büeler H.
    Mol Ther; 2005 Jan 19; 11(1):80-8. PubMed ID: 15585408
    [Abstract] [Full Text] [Related]

  • 7. Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease.
    Iczkiewicz J, Jackson MJ, Smith LA, Rose S, Jenner P.
    Brain Res; 2006 Nov 06; 1118(1):239-50. PubMed ID: 16962083
    [Abstract] [Full Text] [Related]

  • 8. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R.
    Acta Neuropathol; 2008 Jul 06; 116(1):47-55. PubMed ID: 18343932
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish.
    Matsui H, Taniguchi Y, Inoue H, Uemura K, Takeda S, Takahashi R.
    Neurosci Res; 2009 Nov 06; 65(3):263-71. PubMed ID: 19665499
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW.
    Neurosci Lett; 2008 Dec 26; 448(2):184-8. PubMed ID: 18977411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S, Moon M, Park S.
    J Endocrinol; 2009 Sep 26; 202(3):431-9. PubMed ID: 19570816
    [Abstract] [Full Text] [Related]

  • 18. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C.
    Neurobiol Aging; 2010 Jan 26; 31(1):99-103. PubMed ID: 18457903
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.